stage iii adenoid cystic carcinoma of the oral cavity
Showing 1 - 7 of 7
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,
Stage I Adenoid Cystic Carcinoma of the Oral Cavity, Stage I Mucoepidermoid Carcinoma of the Oral Cavity, Stage I Squamous Cell
Terminated
- Stage I Adenoid Cystic Carcinoma of the Oral Cavity
- +27 more
- endoscopic procedure
- questionnaire administration
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jun 29, 2018
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent
Terminated
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +54 more
- transoral robotic surgery
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 7, 2014
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma Trial in Houston (bevacizumab, , magnetic
Completed
- Adult Anaplastic Astrocytoma
- +86 more
- bevacizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 21, 2014
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Adenoid Cystic Carcinoma of the Oral
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +53 more
- hydroxyurea
- +5 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Feb 6, 2013